IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $254,745 | +231.0% | 13,500 | -16.1% | 0.00% | +100.0% |
| Q3 2022 | $76,958 | +1.3% | 16,100 | +57.8% | 0.00% | 0.0% |
| Q4 2021 | $76,000 | -73.6% | 10,200 | -62.8% | 0.00% | -66.7% |
| Q1 2018 | $288,000 | -6.5% | 27,400 | -42.9% | 0.00% | -25.0% |
| Q4 2017 | $308,000 | +126.5% | 48,000 | +169.7% | 0.00% | +100.0% |
| Q3 2017 | $136,000 | – | 17,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |